申请人:FIBROGEN, INC.
公开号:US09409892B2
公开(公告)日:2016-08-09
The present invention relates to novel compounds of formula (I), and compositions capable of inhibiting PHD1 enzyme activity selectively over other isoforms, for example, PHD2 and/or PHD3 enzymes. The invention also relates to compounds of formula (I) for use in disorders such as muscle degeneration, colitis, IBD, and certain ischemias.
本发明涉及公式(I)的新化合物和能够选择性地抑制PHD1酶活性的组合物,例如,PHD2和/或PHD3酶。本发明还涉及公式(I)的化合物,用于治疗肌肉退化、结肠炎、炎症性肠病和某些缺血症。